Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
The Pending NDC and Bar Code Rule: Distributor Perspectives
The FDA has proposed an amendment to its regulations to adopt a uniform, 12-digit format for the NDC. In part two of this series, HDA’s Senior Director, Industry Relations, Tim Stearns discusses the NDC and bar code proposed amendments and analyzes distributors' comments.
HDA Dialogue Explores DE&I Efforts In the Distribution Sector
Discussions surrounding diversity, equity and inclusion (DE&I) are critically important to the healthcare distribution industry as this work ultimately strengthens the industry’s ability to deliver safe, affordable and efficient healthcare to patients across the nation. Earlier this month, HDA hosted a virtual discussion with four industry leaders who are fostering belonging within their organizations.